By Peter A. McCullough, MD, MPH (pictured here)
The US CDC advises on COVID-19 vaccine myopericarditis:
The severity of myocarditis and pericarditis cases can vary; most patients with myocarditis after mRNA COVID-19 vaccination have experienced resolution of symptoms by hospital discharge. CDC has published studies with clinical information about myocarditis and pericarditis after COVID-19 vaccination.
Hospitalization is a concerning outcome for any young person after taking a vaccine that should be safe and have a meaningful health benefit. The CDC guidance does not tell Americans that myopericarditis can be fatal.